跳至主要内容
临床试验/NCT01692964
NCT01692964已完成不适用

Clinical Evaluation of the InflammaDry Device for Detecting Dry Eye

Rapid Pathogen Screening4 个研究点 分布在 1 个国家目标入组 237 人开始时间: 2012年10月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
237
试验地点
4
主要终点
Negative and Positive Agreement of the InflammaDry at Diagnosis of Dry Eyes

研究概览

简要总结

InflammaDry is a rapid diagnostic test for the detection of elevated levels of Matrix Metalloproteinase-9 (MMP-9) protein in tear fluid.

详细描述

The InflammaDry test will be used to aid in the diagnosis of dry eye in conjunction with other methods of clinical evaluation.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age or older
  • Patient voluntarily reported at least 1 episode of any of the following ocular symptoms during the last month:
  • Burning or stinging
  • Sandy or gritty feeling
  • Foreign body sensation
  • Light sensitivity
  • Intermittent or fluctuating vision
  • Exclusion Criteria
  • Allergy to cornstarch or Dacron
  • Allergy to topical anesthetic or fluorescein dye
  • Prior eye injury, trauma, or ocular surgery within the last 3 months
  • Known blockage of the lacrimal drainage system
  • Contact lens wear in the last month
  • Previous corneal refractive surgery including RK, LASIK or PRK surgery
  • Have an active ocular infection or history of a recent ocular infection in the last month
  • Have active intraocular inflammation or history of intraocular inflammation, e.g. Uveitis
  • Use of oral doxycycline, corticosteroids, or immunomodulators in the last month
  • Have received topical ocular corticosteroids, topical Nonsteroidal (NSAIDs) therapy, or topical ocular cyclosporine in the last month
  • Pregnant or lactating
  • Use of any topical ophthalmic medications, including artificial tears 2 hours prior to enrollment

排除标准

  • 未提供

结局指标

主要结局

Negative and Positive Agreement of the InflammaDry at Diagnosis of Dry Eyes

时间窗: 20 minutes

Negative agreement is the percentage of true negative cases compared to clinical assessment (specificity). Positive agreement is the percentage of true positive cases compared to clinical assessment (sensitivity). The InflammaDry test was compared with the clinical assessment of tear break-up time, Schirmer tear testing, and corneal staining for the confirmation of dry eye, both with and without the inclusion of the Ocular Surface Disease Index (OSDI), as a confirmatory test.

次要结局

未报告次要终点

研究者

发起方
Rapid Pathogen Screening
申办方类型
Industry
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验

Clinical Evaluation of the InflammaDry Device for... | 临床试验